Post by
MedStocks2 on Jan 15, 2021 11:28pm
$5 or $10 buyout - Idiots
clearly this board is attracting some true idiots who still don't understand the real value here. The cell pouch with the immune protection tech is essentially the sim card of regenerative medicine. There are hundreds of companies doing in therapeutic cells and Sernova is the only company with a successful device for containing those cells. This company could easily be worth north of $50 a share. Given the results we saw in the press release, we could be on a very short path. The patents are solid and therapeutic cell companies are going to prefer pouring resources into cell lines and not reinventing a cell pouch. Hopefully, anyone foolish enough to think $10 is a good buyout doesn't hold enough shares to carry weight in a vote.
Comment by
Redbaron2211 on Jan 15, 2021 11:58pm
Med, agree we are on a precipice of a major revolution in cell therapy. Sernova is very well positioned to capture this.
Comment by
Redbaron2211 on Jan 16, 2021 12:28am
Long term I agree 10B+ is possible. Short term focus on revaluation with peers and a SP at $6+ is very achievable and could happen alot quicker then we think.